The infected chest wall prosthesis: management by excision and contralateral transverse rectus abdominis musculocutaneous flap.
A patient with a chest wall sarcoma whose original prosthetic reconstruction became infected after a course of radiation therapy is described. After removal of the prosthesis, salvage reconstruction was performed using a transverse rectus abdominis musculocutaneous flap. Management of the infected chest wall prosthesis, with emphasis on the indications for use of the transverse rectus abdominis musculocutaneous flap, is discussed.
Wiebke
E A
EA
Thoracic Oncology Section, National Cancer Institute, Bethesda, MD 20892.
McDonald
H D
HD
Pass
H I
HI
D003131:Combined Modality Therapy; D018219:Histiocytoma, Benign Fibrous / Q000628:therapy; D006801:Humans; D008297:Male; D020366:Methylmethacrylate; D008768:Methylmethacrylates; D008875:Middle Aged; D011095:Polyethylenes; D011126:Polypropylenes; D019736:Prostheses and Implants / Q000009:adverse effects*; D011878:Radiotherapy / Q000009:adverse effects; D013524:Surgical Flaps; D013530:Surgical Wound Infection / Q000601:surgery*; D013896:Thoracic Diseases / Q000601:surgery*; D013899:Thoracic Neoplasms / Q000628:therapy
D008768:Methylmethacrylates; C016674:Plastipore; D011095:Polyethylenes; D011126:Polypropylenes; D020366:Methylmethacrylate